25 results on '"Longo J"'
Search Results
2. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
3. Genetic variation in the nuclear factor (kappa)B pathway in relation to susceptibility to rheumatoid arthritis
4. AB0015 Evaluating The Effect of Anti-TNF, Anti-IL6R and Anti-CTLA4 on ACPA Isotypes in Patients with Rheumatoid Arthritis
5. FRI0619-HPR Joint Prostheses and Biologic Therapies in a Rheumatologic Clinic
6. FRI0424 Cardiovascular Events in Systemic Lupus Erythematosus (Sle): A Nationwide Study in Spain (Relesser Registry)
7. AB0396 Infliximab and Adalimumab Levels and Antidrug Antibodies Detection in Patients with Rheumatoid Arthritis (RA): an Interlaboratory Comparison Using A Commercial ELISA Assay
8. SAT0340 Infliximab Levels and Anti-Infliximab Antibodies Comparison between Two Comercial ELISA Versions in Patients with Ankylosing Spondylitis
9. THU0250 Predictive Value of Doppler Ultrasound-Detected Synovitis in Relation to Successful Tapering of Biology Therapy in Patients with Rheumatoid Arthritis
10. SAT0318 Antisynthetase Syndrome: Clinical and Serological Characteristics at Disease Onset: Table 1.
11. AB0398 Relation between Serum Infliximab Levels and Changes of Rheumatoid Factor and Antibodies to Citrullinated Peptides Levels in Patients with Rheumatoid Arthritis
12. AB0434 Relation of Subclinical Ultrasound Detected Synovitis and Peripheral B-Cell Counts in Rheumatoid Arthritis Patients Treated with Rituximab
13. AB0027 B-Cell Activating Factor (BAFF) Binding Receptors (BBR) on B Cells: Characterization in Patients with Rheumatoid Arthritis (RA) Receiving Biological Therapies: Anti-TNF, Anti-Il6r and Anti-Ctla4: A Longitudinal Study
14. THU0585-HPR Impact on the Therapeutic Response to Anti-Tumor Necrosis Factor (ANTI-TNF) Agents of the Thickness of the Subcutaneous Tissue (SBC) in the Site of Injection Measured by Ultrasound
15. AB0026 B-Cell Profile in RA Patients Treated with Two Different Biological Therapeutic Targets: Anti-TNF and Anti-Il6r. A Cross-Sectional Study
16. THU0187 Does Ultrasound-Scored Synovitis Depend on the Pharmacokinetics of Subcutaneous Anti-TNF Agents in Patients with Rheumatoid Arthritis?: Table 1.
17. AB0041 B-cell activating factor (BAFF) binding receptors (BBR) on B cells: characterization in patients with rheumatoid arthritis (RA) receiving anti-TNF-alpha agent infliximab (IFX)
18. THU0215 Establishing Cut-Off of Infliximab and Anti-Infliximab Antibody Levels Using a Commercial Elisa in Patients with Rheumatoid Arthritis
19. SAT0228 Study of the disease activity and refractoriness to the treatment in a large spanish multicentric cohort of patients with systemic lupus erythematosus
20. THU0180 Prevalence and clinical significance of severe infection in patients with systemic lupus erythematosus: Preliminary data from relesser (registry of lupus of the spanish society of rheumatology)
21. SAT0135 Modified antitnf dose patterns in clinical practice: Achieving clinical control with minimum effective dosages
22. SAT0209 Characterization of pure membranous lupus nephritis: A cohort of 134 patients
23. Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
24. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
25. Anticardiolipin antibodies in drug addicted patients with AIDS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.